{"url":"https://lda.senate.gov/api/v1/filings/b4b780ff-dbc7-424a-b883-e483e2619d7a/","filing_uuid":"b4b780ff-dbc7-424a-b883-e483e2619d7a","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b4b780ff-dbc7-424a-b883-e483e2619d7a/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Taylor Johnson","dt_posted":"2020-09-30T22:09:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.senate.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":206936,"url":"https://lda.senate.gov/api/v1/clients/206936/","client_id":1008365,"name":"AMERICAN PHARMACEUTICAL SERVICES, INC.","general_description":"Manufacture Active Pharmaceutical Ingredients","client_government_entity":false,"client_self_select":null,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Supporting efforts to expand manufacturing and procurement of active pharmaceutical ingredients.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":53590,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"SWEAT","suffix":null,"suffix_display":null},"covered_position":"LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)","new":true}],"government_entities":[]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Supporting efforts to expand manufacturing and procurement of active pharmaceutical ingredients.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":53590,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"SWEAT","suffix":null,"suffix_display":null},"covered_position":"LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)","new":true}],"government_entities":[]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Supporting efforts to expand manufacturing and procurement of active pharmaceutical ingredients.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":53590,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"SWEAT","suffix":null,"suffix_display":null},"covered_position":"LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}